- NCIt
- C35812
Loading cancer entity…
Loading cancer entity…
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03618641 | CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease | completed | Phase 2 | 34 | Diwakar DavarOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT01815333 | Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging | completed | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02298010 | Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial | completed | — | 899 | Seoul National University HospitalOTHER | 0 | May 14, 2019 | clinicaltrials |
Data updated 22 days agoSource updated May 14, 2025source: clinicaltrials